Foresee Pharmaceuticals Co Ltd (6576) — Cash Flow Quality Index
Latest as of June 2022:
6.56x
Foresee Pharmaceuticals Co Ltd (6576) has a Cash Flow Quality Index of 6.56x as of June 2022. Operating cash flow of NT$143.03 Million exceeds net income of NT$21.80 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of Foresee Pharmaceuticals Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
6.56x
Operating CF / Net Income
Operating Cash Flow
NT$143.03 Million
TWD
Net Income
NT$21.80 Million
TWD
Data as of
Jun 2022
Most recent filing
Annual Cash Flow Quality Index for Foresee Pharmaceuticals Co Ltd (None–None)
Year-by-year earnings quality comparison for Foresee Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see Foresee Pharmaceuticals Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.